V02.09.2021  Randomized Trial to T est the E ffect of Rivaroxaban or Apixaban on Menstrual Blood 
Loss in WomEn (RAMBLE ) 
 
[STUDY_ID_REMOVED]  
 
The primary comparison is the frequency of study -defined abnormal uterine bleeding between women 
treated with apixaban, versus women treated with rivaroxaban. The plan was to compare these 
frequencies using 95% confidence intervals for the difference in proportions.  
 